This episode currently has no reviews.
Submit ReviewIn this episode, Molly Gamble, Vice President of Editorial at Becker’s Healthcare discusses announced healthcare executive moves & exits in 2024, Intermountain ending their precision medicine program and healthcare hopeful 23andMe's valuation down 98%.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review